Other
Vaginal Delivery
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Vaginal Delivery is an early-stage landscape with 0 programs across 1 company. The most active players are Ferring.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
27
clinical trials
Completed17 · 63%
Unknown status5 · 19%
Withdrawn2 · 7%
Recruiting1 · 4%
Terminated1 · 4%
Not yet recruiting1 · 4%
Clinical Trials
Trial Activity
27 trials
Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae
Recruiting·—·N/A·NCT06568289·60 enrolled
Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery
Completed·—·Phase 3·NCT03166111·216 enrolled
Failure of Vaginal Delivery After Induction
Completed·—·Phase 3·NCT02758340·335 enrolled
Use of Tranexamic Acid After Vaginal Delivery with Episiotomy a RCT Placebo Control Trail
Completed·—·Phase 4·NCT05448456·150 enrolled
Thermosensitive Gels for the Vaginal Delivery of Sildenafil Citrate
Completed·—·Phase 2/3·NCT02766725·90 enrolled
Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery
Completed·—·N/A·NCT03708497·360 enrolled
Prophylactic Tranexamic Acid Use After Vaginal Delivery
Completed·—·N/A·NCT05429580·480 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)